The SpyGlass Pharma Drug Delivery Platform (Malik Y. Kahook, MD)

The SpyGlass Pharma Drug Delivery Platform holds great promise for glaucoma management. The initial product development is focused on delivering 3 years of bimatoprost therapy to lower intraocular pressure in patients with glaucoma or ocular hypertension. Pipeline projects are also advancing to address other eye conditions, including delivering post operative Steroids and NSAIDS, as well as treating Chronic Uveitis and potentially Age-related Macular Degeneration. Visit www.spyglasspharma.com for more information. #Ophthalmology #PlatformTechnology #DrugDelivery #EyeCare #glaucoma #cataracts #Eye #Surgery #SpyGlasspharma